ファルカリンジオールは,JAK/ STAT3軸の調節により,悪性がんの進行を抑制し,非小細胞肺がんにおけるフェロプトーシスを誘発する
Zhenliang Shi1, Yimeng Shen1, Xin Liu1
1Department of Thoracic Surgery, Chest Hospital, Tianjin University, Tianjin, China.
Journal of biochemical and molecular toxicology
|September 3, 2025
まとめ
ファルカリンジオール (FAD) は,フェロプトーシスを誘発し,JAK/ STAT3経路を阻害することによって,非小細胞肺がん (NSCLC) の成長と拡散を抑制する. この化合物は,正常な細胞に対する有意な毒性なしにNSCLCの治療に希望を示しています.
科学分野:
- 腫瘍学
- 分子生物学
- 生物化学
背景:
- 非小細胞肺がん (NSCLC) は,がんによる死亡の主な原因です.
- ファルカリンジオール (FAD) は様々ながんに抗腫瘍効果を示しているが,NSCLCにおけるその役割は未知のままである.
- NSCLCにおけるFADのメカニズムの理解は,新しい治療戦略の開発に不可欠です.
研究 の 目的:
- 非小細胞肺がん (NSCLC) 細胞および体内モデルにおけるファルカリンジオール (FAD) の抗癌効果を調査する.
- FADがNSCLCに及ぼす影響の基礎となる分子機構を解明する.
- 非癌性肺細胞におけるFADの安全性を評価する.
主な方法:
- FADの細胞毒性およびNSCLCの細胞増殖への影響を評価するために,細胞計測キット-8 (CCK-8) を使用した.
- タンパク質発現,細胞侵入,ミトコンドリア形態の変化を評価するために,ウエスタン・ブラット分析,トランスウェル解析,および免疫光法が使用された.
- フェロプトーシスの誘発におけるFADの役割を決定するために,Fe2+と活性酸素種 (ROS) のレベルを測定した.
- FADの有効性を in vivoで評価するために,腫瘍の異種移植モデルを使用し,その後の免疫ヒストキミストリーとウェスタンブロット分析を行いました.
主要な成果:
- FADは160μM以下の濃度では正常な肺細胞に対する有意な細胞毒性 (BEAS- 2B) を示さなかった.
- FADはNSCLC細胞の増殖と侵入を抑制し,PCNA,ki-67,N-カデリンなどのマーカーを低下させ,E-カデリンを増加させた.
- FADは,ミトコンドリアの断片化を誘導すると同時に,Fe2+とROSのレベルを上昇させ,GPX4とxCTを減少させ,NSCLC細胞におけるフェロプトーシスを誘導した.
- In vivoでは,FADは腫瘍の体積と体重を減らし,増殖マーカーを抑制し,フェロプトーシスに関連するタンパク質を調節し,これらはすべてJAK/ STAT3経路の活性化によって逆転した.
結論:
- ファルカリンジオール (FAD) は,非小細胞肺がん (NSCLC) の増殖と侵入を効果的に抑制する.
- FADはフェロプトーシスとミトコンドリア機能障害によってNSCLC細胞死を引き起こす.
- NSCLCにおけるFADの抗癌効果は,JAK/ STAT3シグナル伝達経路の阻害によって媒介される.
関連する概念動画
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K


